Timothy Scannell

Mr. Scannell joined the Board in June of 2022. He is currently an Executive Advisor at Stryker Corporation, a position he has held since retiring from his role as President and Chief Operating Officer in September 2021. Mr. Scannell served as President and Chief Operating Officer of Stryker from 2018 to 2021. Prior to this position, he served as Group President, responsible for the MedSurg and Neurotechnology businesses at Stryker from 2008-2018. Prior to the Group President role, Mr. Scannell served as Vice President/General Manager of Stryker Biotech and President of Stryker Spine. Mr. Scannell is a Director and Chair of the Board of Insulet Corporation and a Director of Novocure, Renalytix, and AeroClean Technologies.